Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 5Phase 3 3Phase 1 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 2Thoracic 1

Conditions

Stomach Neoplasms 1Psychological Well-Being 1Pancreatic Neoplasms 1Motor Activity 1Lung Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Radiation 24Panitumumab 24Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Curcumin × Gastrointestinal × Clear all
NCT04871412 2026-01-30

POISE

Ottawa Hospital Research Institute

Phase 3 Recruiting
20 enrolled
GastrointestinalThoracic

Psychological Well-Being, Esophageal Neoplasms, Lung Neoplasms, Motor Activity, Stomach Neoplasms

NCT00486460 2007-06-14

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
Gastrointestinal

Pancreatic Neoplasms

NCT00295035 2006-02-22

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
100 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡